OncoSec Medical Incorporated
ONCSQ
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 16.17% | -22.36% | -53.77% | -11.59% | -16.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.62% | -26.31% | -41.40% | -8.52% | -21.70% |
| Operating Income | 18.62% | 26.31% | 41.40% | 8.52% | 21.70% |
| Income Before Tax | 30.76% | 17.81% | 42.19% | -1.52% | 7.46% |
| Income Tax Expenses | 0.00% | -- | 100.00% | -222,573.33% | 100.00% |
| Earnings from Continuing Operations | 30.75% | 17.81% | 30.35% | 33.84% | 7.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.75% | 17.81% | 30.35% | 33.84% | 7.44% |
| EBIT | 18.62% | 26.31% | 41.40% | 8.52% | 21.70% |
| EBITDA | 18.71% | 26.46% | 41.57% | 8.58% | 21.87% |
| EPS Basic | 52.17% | 18.25% | 30.93% | 37.23% | 32.49% |
| Normalized Basic EPS | 52.18% | 18.25% | 42.68% | 12.59% | 38.27% |
| EPS Diluted | 52.17% | 18.25% | 30.93% | 37.23% | 32.49% |
| Normalized Diluted EPS | 52.18% | 18.25% | 42.68% | 12.59% | 38.27% |
| Average Basic Shares Outstanding | 44.78% | 0.53% | 0.85% | 5.41% | 37.09% |
| Average Diluted Shares Outstanding | 44.78% | 0.53% | 0.85% | 5.41% | 37.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |